City

Houston (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

M.D. Anderson Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

erlotinib hydrochloride (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

stage 0is urethral cancer ajcc v8

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recurrent Bladder Urothelial Carcinoma, Recurrent Renal Pelvis Urothelial Carcinoma, Recurrent Ureter Urothelial Carcinoma Trial

Completed

Recurrent Bladder Urothelial Carcinoma
+19 more

Erlotinib Hydrochloride

Houston, Texas

M D Anderson Cancer Center

Aug 21, 2020